A framework for integrating evidence to assess hazards and risk

References

• Applegate CC, Rowles JK, 3rd, Erdman JW. Jr. 2019. Can lycopene impact the androgen axis in prostate cancer?: a systematic review of cell culture and animal studies. Nutrients. 11(3):633. doi: 10.3390/nu11030633.
   PubMed Web of Science ®Google Scholar
• Burns CJ, LaKind JS. 2021. Using the matrix to bridge the epidemiology/risk assessment gap: a case study of 2,4-D. Crit Rev Toxicol. 51(7):591–599. doi: 10.1080/10408444.2021.1997911.
   PubMed Web of Science ®Google Scholar
• Dekant W, Bridges J. 2016. A quantitative weight of evidence methodology for the assessment of reproductive and developmental toxicity and its application for classification and labelling of chemicals. Regul Toxicol Pharmacol. 82:173–185. doi: 10.1016/j.yrtph.2016.09.009.
   PubMed Web of Science ®Google Scholar
• EFSA (European Food Safety Authority). 2017a. Guidance on the assessment of the biological relevance of data in scientific assessments. EFSA J. 15(8):4970.
   Web of Science ®Google Scholar
• EFSA (European Safety Authority). 2017b. Guidance on the use of the weight of evidence approach in scientific assessments. EFSA J. 15(8):4971.
   Web of Science ®Google Scholar
• European Commission (Scientific Committee on Health, Environmental and Emerging Risks (SCHEER)). 2018. Memorandum on weight of evidence and uncertainties Revision 2018. https://health.ec.europa.eu/system/files/2019-02/scheer_o_014_0.pdf.
   Google Scholar
• Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, Debeer H, et al. 2011. GRADE guidelines: 1. Introduction – GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 64(4):383–394. doi: 10.1016/j.jclinepi.2010.04.026.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell. 144(5):646–674. doi: 10.1016/j.cell.2011.02.013.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine. 2010. Gulf war and health. Volume 8: update of health effects of serving in the Gulf war. Committee on Gulf water and health: health effects of serving in the Gulf war, update 2009. Washington, DC: Board on the Health of Select Populations, Institute of Medicine of the National Academies, The National Academies Press.
   Google Scholar
• Jensen K, Afroze S, Munshi MK, Guerrier M, Glaser SS. 2012. Mechanisms for nicotine in the development and progression of gastrointestinal cancers. Transl Gastrointest Cancer. 1:81–87.
   PubMedGoogle Scholar
• Klimisch HJ, Andreae M, Tillmann U. 1997. A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regul Toxicol Pharmacol. 25(1):1–5. doi: 10.1006/rtph.1996.1076.
   PubMed Web of Science ®Google Scholar
• Krewski D, Saunders-Hastings P, Baan RA, Barton-Maclaren TS, Browne P, Chiu WA, Gwinn M, Hartung T, Kraft AD, Lam J, et al. 2022. Development of an evidence-based risk assessment framework. ALTEX. 39(4):667–693. doi: 10.14573/altex.2004041.
   PubMedGoogle Scholar
• LaKind JS, Naiman J, Burns CJ. 2020. Translation of exposure and epidemiology for risk assessment: a shifting paradigm. Int J Environ Res Public Health. 17(12):4220. doi: 10.3390/ijerph17124220.
   PubMed Web of Science ®Google Scholar
• Lang S, Kleijnen J. 2010. Quality assessment tools for observational studies: lack of consensus. Int J Evid Based Healthc. 8(4):247. doi: 10.1111/j.1744-1609.2010.00195.x.
   PubMedGoogle Scholar
• Mohler D, Liberati A, Tetzlaff J, Altman DG, The Prisma Group. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 151(4):264–269.
   PubMed Web of Science ®Google Scholar
• National Research Council. 2014. Review of EPA’s integrated risk information system (IRIS) process. Washington, DC: Committee to Review the IRIS Process, Board on Environmental Studies and Toxicology, Division on Earth and Life Studies, National Research Council, The National Academies Press.
   Google Scholar
• National Toxicology Program. 2019a. Report on carcinogen process and listing criteria. National Toxicology Program, United States Department of Health and Human Services. https://ntp.niehs.nih.gov/pubhealth/roc/process/index.html.
   Google Scholar
• National Toxicology Program. 2019b. Handbook for conducting a literature-based health assessment using OHAT approach for systematic review and evidence integration. Office of Health Assessment and Translation, Division, National Toxicology Program, National Institute of Environmental Health Sciences. March 4, 2019 [online]. https://ntp.niehs.nih.gov/ntp/ohat/pubs/handbookmarch2019_508.pdf.
   Google Scholar
• OECD. 2018. Users’ handbook supplement to the guidance document for developing and accessing adverse outcome pathways, Series on Testing and Assessment No. 233. Series on Adverse Outcome Pathways No. 1.
   Google Scholar
• OECD. 2019. Guiding principles and key elements for establishing a weight of evidence for chemical assessment, Series on Testing and Assessment No. 311, Environment, Health and Safety Division, Environment Directorate. https://www.oecd.org/chemicalsafety/risk-assessment/guiding-principles-and-key-elements-for-establishing-a-weight-of-evidence-for-chemical-assessment.pdf.
   Google Scholar
• Sanderson S, Tatt IT, Higgins PT. 2007. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol. 36(3):666–676. doi: 10.1093/ije/dym018.
   PubMed Web of Science ®Google Scholar
• Schwarzman MR, Ackerman JM, Dairkee SH, Fenton SE, Johnson D, Navarro KM, Osborne G, Rudel RA, Solomon GM, Zeise L, et al. 2015. Screening for chemical contributions to breast cancer risk: a case study for chemical safety evaluation. Environ Health Perspect. 123(12):1255–1264. doi: 10.1289/ehp.1408337.
   PubMed Web of Science ®Google Scholar
• Senga SS, Grose RP. 2021. Hallmarks of cancer-the new testament. Open Biol. 11(1):200358.
   PubMed Web of Science ®Google Scholar
• Smith MT, Guyton KZ, Kleinstreuer N, Borrel A, Cardenas A, Chiu WA, Felsher DW, Gibbons CF, Goodson WH, 3rd, Houck KA, et al. 2020. The key characteristics of carcinogens: relationship to the hallmarks of cancer, relevant biomarkers, and assays to measure them. Cancer Epidemiol Biomarkers Prev. 29(10):1887–1903. doi: 10.1158/1055-9965.EPI-19-1346.
   PubMed Web of Science ®Google Scholar
• Sulsky SI, Hooven FH, Burch MT, Mundt KA. 2002. Critical review of the epidemiological literature on the potential cardiovascular effects of occupational carbon disulfide exposure. Int Arch Occup Environ Health. 75(6):365–380. doi: 10.1007/s00420-001-0309-x.
   PubMed Web of Science ®Google Scholar
• Suter G, Nichols J, Lavoie E, Cormier S. 2020. Systematic review and weight of evidence are integral to ecological and human health assessments: they need an integrated framework. Integr Environ Assess Manag. 16(5):718–728. doi: 10.1002/ieam.4271.
   PubMed Web of Science ®Google Scholar
• USEPA (Untied States Environmental Protection Agency). 1986. Guidelines for Carcinogen Risk Assessment. Washington, DC: United States Environmental Protection Agency (USEPA), Risk Assessment Forum. Published on September 24, 1986, EPA/630/R-00/004. Fed Register 51(185), 33992–34003.
   Google Scholar
• USEPA (United States Environmental Protection Agency). 2011. Endocrine Disruptor Screening Programme, 2011. Weight-of-evidence guidance document: https://www.epa.gov/endocrinedisruption/endocrine-disruptor-screening-program-documents. Direct link to guidance document: https://www.regulations.gov/document?D=EPA-HQ-OPPT-2010-0877-0021.
   Google Scholar
• USEPA (United States Environmental Protection Agency). 2016. Weight of evidence in ecological assessment. EPA/100/R-16/001. Washington, DC, December.
   Google Scholar
• USEPA (United States Environmental Protection Agency). 2018. Application of systematic review in TSCA evaluations. Office of Chemical Safety and Pollution Prevention. EPA Document# 740-P1-8001.
   Google Scholar
• Vandenberg LN, Ågerstrand M, Beronius A, Beausoleil C, Bergman Å, Bero LA, Bornehag CG, Boyer CS, Cooper GS, Cotgreave I, et al. 2016. A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals. Environ Health. 15(1):74. doi: 10.1186/s12940-016-0156-6.
   PubMedGoogle Scholar
• Villeneuve DL, Angrish MM, Fortin MC, Katsiadaki I, Leonard M, Margiotta-Casaluci L, Munn S, O'Brien JM, Pollesch NL, Smith LC, et al. 2018. Adverse outcome pathway networks II: network analytics. Environ Toxicol Chem. 37(6):1734–1748. doi: 10.1002/etc.4124.
   PubMed Web of Science ®Google Scholar
• Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M, Hutchinson TH, LaLone CA, Landesmann B, Lettieri T, Munn S, Nepelska M, et al. 2014a. Adverse outcome pathway (AOP) development I: strategies and principles. Toxicol Sci. 142(2):312–320.
   PubMed Web of Science ®Google Scholar
• Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M, Hutchinson TH, LaLone CA, Landesmann B, Lettieri T, Munn S, Nepelska M, et al. 2014b. Adverse outcome pathway development II: best practices. Toxicol Sci. 142(2):321–330.
   PubMed Web of Science ®Google Scholar
• Vincent MJ, Parker A, Maier A. 2017. Cleaning and asthma: a systematic review and approach for effective safety assessment. Regul Toxicol Pharmacol. 90:231–243. doi: 10.1016/j.yrtph.2017.09.013.
   PubMed Web of Science ®Google Scholar
• Whaley P, Edwards SW, Kraft A, Nyhan K, Shapiro A, Watford S, Wattam S, Wolffe T, Angrish M. 2020. Knowledge organization systems for systematic chemical assessments. Environ Health Perspect. 128(12):125001. doi: 10.1289/EHP6994.
   PubMed Web of Science ®Google Scholar
• Wikoff D, Lewis RJ, Erraguntla N, Franzen A, Foreman J. 2020. Facilitation of risk assessment with evidence-based methods – a framework for use of systematic mapping and systematic reviews in determining hazard, developing toxicity values, and characterizing uncertainty. Regul Toxicol Pharmacol. 118:104790. doi: 10.1016/j.yrtph.2020.104790.
   PubMed Web of Science ®Google Scholar
• Wu W, Cho C. 2004. The pharmacological actions of nicotine on the gastrointestinal tract. J Pharmacol Sci. 94:348–358.
   PubMed Web of Science ®Google Scholar